HIV Diagnostics Market Size To Reach $1550.17 Million By 2030

HIV Diagnostics Market Size Growth & Trends

The global HIV diagnostics market is expected to reach USD 1550.17 million by 2030, growing at an estimated CAGR of 5.5% from 2023 to 2030, according to a new study by Grand View Research, Inc. Key factors accounting for the growth of this market include the growing need in for the development of more sensitive HIV diagnostic point of care tests which can be easily implemented at the location of patient care in resource-limited settings. Technological development of tests which is expected to introduce a number of novel rapid, point-of-care tests throughout the forecast period is a primary factor expected to fuel the growth of the HIV diagnostics market. Furthermore, government programs and campaigns initiated against HIV, global healthcare efforts to reduce disease incidence, and the presence of high unmet demand in the Middle Eastern and Eastern regions of the market are some key factors expected to serve as lucrative future growth opportunities.

 Request a free sample copy or view report summary: HIV Diagnostics Market Report

HIV Diagnostics Market Report Highlights

• The antibody test type segment dominated the industry and accounted for the largest revenue share of 53.3% in 2022. This large share can be accounted for by the high market usage and penetration rates of these tests which include, ELISA, home access dried blood spot, western blot testing IFA, and RIPA.  These tests are highly sensitive and accurate and thus are most commonly used for screening and confirmation of HIV-1 & HIV-2.

• Viral Load testing and CD4 testing also accounted for a considerable share of the market in 2022. There is a prevalent in the market for the development of these tests which will make them more sensitive, rapid in nature, and portable to the point of care to enhance their market usability and accessibility in resource-limited HIV-affected regions.

• It is expected that during the forecast period, a number of novel point-of-care HIV diagnostic products will be commercialized which are currently under clinical development and in product pipelines of key market players. This increase in the range of products is expected to fuel the growth of this market over the forecast period.

• Asia Pacific dominated the market and accounted for the largest revenue share of 35.7% in 2022 owing to technological advancement, an increase in the number of people suffering from HIV and AIDS, and increasing awareness regarding the same in this region.

• Latin America is expected to grow at the fastest CAGR of 6.9% during the forecast period owing to the increasing awareness about diagnostic testing in the region.

HIV Diagnostics Market Segmentation

Grand View Research has segmented the HIV diagnostics market on the basis of test type, product, mode, end-use and region:

HIV Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Consumables

• Instruments

• Software and Services

HIV Diagnostics Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Self-test

• Lab-based

HIV Diagnostics Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• Antibody Test

  • HIV-1 Screening Tests

    • ELISA/EIA

    • Home Access Dried Blood Spot

    • Rapid Tests (Dot plot, Agglutination Tests)

  • HIV-1 Antibody Confirmatory Tests

    • Western Blot Test

    • Indirect Immunofluorescent Antibody Assay (IFA)

    • Line Immunoassay

    • RadioImmunoPrecipitation Assay (RIPA)

  • HIV-2 & Group O Diagnostic Tests

    • Blood Antibody Tests

    • Dried Blood Spot (DBS) Test

    • Others and (Oral, Urine)

• Viral Load Test

• CD4 Test

• Others

HIV Diagnostics End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostic Laboratories

• Hospitals & Clinics

• Home Settings

HIV Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in the HIV Diagnostics Market

• Alere Inc.

• Abbott

• Bristol-Myers Squibb Company

• Janssen Global Services, LLC

• Gilead Sciences, Inc.

• Merck & Co. Inc.

• VIIV Healthcare

• BD

• Beckman Coulter, Inc.

• Sysmex Europe SE

• Apogee Flow Systems

• Point Care

• Zyomtronix, Inc.

• Mylan N.V.

• F. Hoffmann-La Roche Ltd.

• Siemens Healthcare GmbH

• QIAGEN